<DOC>
	<DOCNO>NCT02121301</DOCNO>
	<brief_summary>The purpose study evaluate whether SkQ1 ophthalmic solution safe effective compare placebo treatment sign symptom dry eye syndrome .</brief_summary>
	<brief_title>A Clinical Study Assess Safety Efficacy Ophthalmic Solution ( SkQ1 ) Treatment Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Be male female race , least 18 year age Have provide write informed consent Have report history dry eye syndrome Have history use desire use eye drop dry eye Have clinically significant eye finding require therapeutic treatment may interfere study parameter Have previously LASIK surgery within last 12 month Have use RestasisÂ® within 30 day Visit 1 Be woman pregnant , nurse planning pregnancy Be unwilling submit urine pregnancy test childbearing potential Have know allergy and/or sensitivity test article component , include preservative benzalkonium chloride Be currently enrol investigational drug device study use investigational drug device within 30 day Visit 1 Have condition situation investigator feel may put subject significant risk , may confound study result , may interfere significantly subject 's participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Dry Eye</keyword>
	<keyword>Dry Eye Syndrome</keyword>
	<keyword>SkQ1</keyword>
	<keyword>KCS</keyword>
	<keyword>Keratoconjunctivitis</keyword>
</DOC>